Healthcare / Health Information ServicesKOSDAQ
$2030.00
-130.00 (-6.02%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-16.3B · quality 69.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
21/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$37.1B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-54.7%
↓Gross Margin
100.0%
↑Debt/Equity
0.22
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+141.3%
FCF CAGR
—
FCF margin
-313.0%
FCF / Net income
0.62x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.43B · net income $-17.38B · FCF $-10.73B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.43B | $3.43B | $120.9M | $123.4M | $244.0M |
| Net Income | $-17.38B | $-17.38B | $-7.21B | $-11.40B | $-4.51B |
| EBITDA | $-12.51B | $-12.51B | $-2.95B | $-9.26B | $-1.78B |
| EPS | -1115.00 | -1115.00 | -790.00 | -796.00 | -333.00 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -313.9% | -313.9% | -11805.3% | -9947.9% | -4833.0% |
| Net Margin | -506.8% | -506.8% | -5966.9% | -9235.9% | -1847.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.22 | 0.22 | 0.29 | 0.07 | 0.35 |
| Current Ratio | 1.16 | 1.16 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-10.73B | $-10.73B | $-16.33B | $-17.51B | $-17.27B |
| Returns | |||||
| ROE | -54.7% | -54.7% | -28.9% | -36.5% | -14.3% |
| Valuation | |||||
| P/B | 1.00 | 1.00 | 4.19 | 7.17 | 3.97 |
| Growth & Yield | |||||
| Revenue Growth | 2736.7% | 2736.7% | -2.0% | -49.4% | — |
| EPS Growth | -41.1% | -41.1% | 0.8% | -139.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-73.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-790.00 → -1115.00
Residual
-73.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.